Enterprise Value to EBITDA Multiple ratio Analysis of Voyager Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Good EV to EBITDA
5.41
Period Ending - Dec-22
Very Poor EV to EBITDA
-5.88
Growth
191.96 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-32.10
EV to EBITDA Analysis of Voyager Therapeutics Inc
| EV to EBITDA Ratio of VYGR rose handsomely by 191.96 % this year. |
| EV to EBITDA Ratio with value of 5.41 was highest in Year Dec-23 in last Five Years. |
| EV to EBITDA Ratio with value of -5.88 was lowest in Year Dec-22 in last Five Years. |
| Latest EV to EBITDA Ratio with value of 5.41 is Greater than Average EV to EBITDA of -0.733 in last five years. |
Other EV to EBITDA Related Info of VYGR that may interest you.
Voyager Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| VYGR | 8.4 | 8.14 | 3.19 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Voyager Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | 5.41 | -5.88 | -3.10 | 5.26 | -5.36 | -2.58 | -2.80 |
| Change | 191.96 % | -89.92 % | -158.85 % | 198.28 % | -107.87 % | 8.04 % | 37.03 % |
FY Chart of Enterprise Value to EBITDA Multiple of Voyager Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)